73 presentations from Casey Eye Institute faculty and researchers at the ARVO 2025 Annual Meeting.

The study by OHSU researchers unlocks potential new treatment options for a leading cause of blindness

Community and Global Outreach 2024 Impact Report.

AI-powered tool assesses glaucoma risk using electronic health record data, expanding access to eye care.

Revolutionizing gene therapy with cutting-edge lipid nanoparticle technology that may offer hope to patients.

Combining AI with ultra-high-resolution OCT imaging used in breakthrough approach to tackle uveitis.

Researcher team fights glaucoma on multiple fronts, their efforts fueled by generous donors.

Elks Children’s Eye Clinic doctors provide kids with patches and glasses, regardless of their ability to pay.

Donations enable OHSU Casey Outreach Program to obtain second mobile unit

Stem cells could revolutionize both early detection and treatment of glaucoma.

Capturing photoreceptor dysfunction in a relatively wide area of the macula in Patients with Retinal Disease.

Clinical Trials at Casey Hold Global Promise.

New Center Brightens the Future for People with Inherited Retinal Diseases.

Huang recognized with National Medal of Technology and Innovation for co-inventing transformative technology

Elks Preschool Vision Screening Program has screened more than 65,000 Oregon children since 2003.

Prize recognizes wide use of optical coherence tomography to manage eye disease, prevent blindness.

About 2,500 miles from its nearest neighbor, Hawaii, American Samoa is as remote as it gets. That’s...

A new way of practicing eye care could have a profound effect on our goal to end preventable blindness in...

OHSU Casey Eye Institute part of clinical trial evaluating potential treatment for inherited blindness.

Highlights of Casey Eye Institute's transformative work in ophthalmology research and clinical care, which...

The Oregon Vision Health Network is expanding our model of eye care from individual to population health.

A collaboration among OHSU cancer researchers reveals which cases of ocular melanoma are likely to spread.

The new center explores exciting possibilities for treating inherited retinal diseases that lead to blindness.

David Huang, M.D., Ph.D., recognized for co-creating widely used medical imaging technology.

Researchers now have a model for testing gene therapy as a treatment for leading cause of blindness-deafness.

New OHSU, OSU research uses lipid nanoparticles to target light-sensitive cells in the eye.

The eye is known as the window to the body, and the cornea is known as the window to the eye. The clear...

On October 8 the Casey community and the Oregon State Elks Association were finally able to celebrate the...

OHSU School of Medicine Interim Dean David Jacoby has appointed Andreas K. Lauer, M.D., director of the...

Myopia, also known as nearsightedness, is on the rise in the U.S. and around the world—particularly among....

The COVID pandemic, has posed particular challenges for research activities at Casey, and all of OHSU...

Facial Nerve Center is the only place in Oregon to offer cutting edge facial reanimation surgery.

Glaucoma researchers at OHSU Casey Eye Institute work cooperatively to improve glaucoma care. Many...

OHSU Casey Eye Institute is a leader in noninvasive imaging technology to detect vascular changes in the eye..

How can we improve the evaluation and care of patients with glaucoma? Early diagnosis is key.

Casey patient JoDee Hambright can see stars for the first time thanks to gene therapy.

Adding a new class of residents improves ophthalmology training experience.

Portland-based OHSU Casey Eye Institute team collaborates with community health clinics across Oregon to...

NIH awards $6.7M total to research team that includes OHSU Casey Eye Institute

Oregon woman with impaired vision hopes medical advances will mean children with CEP290 gene mutations...

Philanthropic gifts totaling $3.25 million will support OHSU Casey Eye Institute Community Outreach Program.

OHSU Casey Eye Institute is a pioneer in the use of computers to support patient care. We were among the...

Ophthalmic imaging expert Yali Jia, Ph.D. and her team constructed a spectroscopic optical coherence...

On Feb. 25, 2020, OHSU Casey Eye Institute led a unique moment in human history—the first gene editing...

The OHSU Casey Eye Institute has used a stem cell therapy in the retina for the first time as part of a...

New facility is welcoming space where sight-saving research, patient care and outreach can flourish.

David Huang, M.D., Ph.D., recognized by Sanford and Susan Greenberg Prize to End Blindness.

OHSU Casey Community Outreach Program’s mobile eye clinic celebrates 10 years.

Michael Chiang, M.D., will begin new role at NIH research institute in late 2020.

BRILLIANCE clinical trial aims to enable sight in people born with a blindness-causing mutation.

Artificial intelligence algorithm receives FDA breakthrough device status.

OHSU is part of multi-center study testing teprotumumab for thyroid eye disease.

Oregon National Primate Research Center at OHSU reports first-ever nonhuman primate model for Bardet-Biedl...

Junior biology major works to ‘solve my own problem and also help others’.

OHSU’s Kathryn Marxen-Simonson teaches use of tech, tools to improve quality of life.

David Wilson, M.D., was appointed the inaugural recipient of the Paul H. Casey Chair in Ocular Oncology...

Last beam raised to top out Elks Children’s Eye Clinic.

Portland boy among first in Oregon to have new treatment for rare, blindness-causing genetic mutation.

Fraternal order gives $20M to build new Oregon Elks Children’s Eye Clinic.

OHSU study find little difference between in-person, remote exams.